Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NABP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | CCNJ | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | FRG1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | LUC7L | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | AMD1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | SGSH | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | AC006386.1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | PTTG1IP | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | PSG4 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | PINK1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |